+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Amniocentesis Needle Market 2019-2023 - Product Image

Global Amniocentesis Needle Market 2019-2023

  • ID: 4755298
  • Report
  • February 2019
  • Region: Global
  • 130 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • BD
  • Cardinal Health
  • Integra LifeSciences
  • Medline Industries Inc.
  • Smiths Group plc
  • The Cooper Companies Inc.
  • MORE
Undergoing the amniocentesis procedure provides certain opportunities to both the expectant mother and her families. Amniocentesis yields genetic test results with very high accuracy. It can detect neural tube defects and abdominal wall defects in a pregnant woman. Amniocentesis is the only test Mere amino fluid is taken for testing, which contains the fetus' cells and proteins. In the presence of congenital disorder in the fetus, the parent can opt for termination (abortion) or decide to carry on with the pregnancy.

Amniocentesis and CVS can reliably detect serious genetic abnormalities, which otherwise remain undetected with prenatal screening and prenatal genetic testing. This is a major advantage as care and treatment can be started early if results prove positive. Hence, there is an increasing demand for the amniocentesis procedure for prenatal diagnosis, thereby driving market growth. The analysts have predicted that the amniocentesis needle market will register a CAGR of almost 4% by 2023.

Market Overview

Increase in pregnancy rate

The teen birth rate in the US is higher than that in many other developed countries such as Canada and the UK. Thus, the increase in pregnancy rates will indirectly result in the rise of prenatal diagnosis through procedures such as amniocentesis, thereby driving the global amniocentesis needle market.

Lack of awareness of amniocentesis technique

The popularity of prenatal diagnosis and its efficacy in detecting genetic disorders depends, to a large extent, on the awareness and acceptability of available methods. The lack of awareness of the amniocentesis procedure can lead to marginal demand for this technique, thereby restricting market growth.

For the detailed list of factors that will drive and challenge the growth of the amniocentesis needle market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be moderately fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • BD
  • Cardinal Health
  • Integra LifeSciences
  • Medline Industries Inc.
  • Smiths Group plc
  • The Cooper Companies Inc.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
  • Market segmentation by application
  • Comparison by application
  • Amniocentesis - Market size and forecast 2018-2023
  • Fetal blood transfusion - Market size and forecast 2018-2023
  • Amnioreduction - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by application
PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER
  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals - Market size and forecast 2018-2023
  • Diagnostic laboratories - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by end-user
PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • BD
  • Cardinal Health
  • Integra LifeSciences
  • Medline Industries, Inc.
  • Smiths Group plc
  • The Cooper Companies, Inc.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Application - Market share 2018-2023 (%)
Exhibit 18: Comparison by application
Exhibit 19: Amniocentesis - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Amniocentesis - Year-over-year growth 2019-2023 (%)
Exhibit 21: Fetal blood transfusion - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Fetal blood transfusion - Year-over-year growth 2019-2023 (%)
Exhibit 23: Amnioreduction - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Amnioreduction - Year-over-year growth 2019-2023 (%)
Exhibit 25: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Others - Year-over-year growth 2019-2023 (%)
Exhibit 27: Market opportunity by application
Exhibit 28: Customer landscape
Exhibit 29: End-user - Market share 2018-2023 (%)
Exhibit 30: Comparison by end-user
Exhibit 31: Hospitals - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Hospitals - Year-over-year growth 2019-2023 (%)
Exhibit 33: Diagnostic laboratories - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Diagnostic laboratories - Year-over-year growth 2019-2023 (%)
Exhibit 35: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Others - Year-over-year growth 2019-2023 (%)
Exhibit 37: Market opportunity by end-user
Exhibit 38: Market share by geography 2018-2023 (%)
Exhibit 39: Geographic comparison
Exhibit 40: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 41: North America - Year-over-year growth 2019-2023 (%)
Exhibit 42: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 43: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 44: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 45: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 46: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 47: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 48: Key leading countries
Exhibit 49: Market opportunity
Exhibit 50: Impact of drivers and challenges
Exhibit 51: Vendor landscape
Exhibit 52: Landscape disruption
Exhibit 53: Vendors covered
Exhibit 54: Vendor classification
Exhibit 55: Market positioning of vendors
Exhibit 56: BD - Vendor overview
Exhibit 57: BD - Business segments
Exhibit 58: BD - Organizational developments
Exhibit 59: BD - Geographic focus
Exhibit 60: BD - Segment focus
Exhibit 61: BD - Key offerings
Exhibit 62: Cardinal Health - Vendor overview
Exhibit 63: Cardinal Health - Business segments
Exhibit 64: Cardinal Health - Organizational developments
Exhibit 65: Cardinal Health - Geographic focus
Exhibit 66: Cardinal Health - Segment focus
Exhibit 67: Cardinal Health - Key offerings
Exhibit 68: Integra LifeSciences - Vendor overview
Exhibit 69: Integra LifeSciences - Business segments
Exhibit 70: Integra LifeSciences - Geographic focus
Exhibit 71: Integra LifeSciences - Segment focus
Exhibit 72: Integra LifeSciences - Key offerings
Exhibit 73: Medline Industries, Inc. - Vendor overview
Exhibit 74: Medline Industries, Inc. - Key offerings
Exhibit 75: Smiths Group plc - Vendor overview
Exhibit 76: Smiths Group plc - Business segments
Exhibit 77: Smiths Group plc - Organizational developments
Exhibit 78: Smiths Group plc - Geographic focus
Exhibit 79: Smiths Group plc - Segment focus
Exhibit 80: Smiths Group plc - Key offerings
Exhibit 81: The Cooper Companies, Inc. - Vendor overview
Exhibit 82: The Cooper Companies, Inc. - Business segments
Exhibit 83: The Cooper Companies, Inc. - Organizational developments
Exhibit 84: The Cooper Companies, Inc. - Geographic focus
Exhibit 85: The Cooper Companies, Inc. - Segment focus
Exhibit 86: The Cooper Companies, Inc. - Key offerings
Exhibit 87: Validation techniques employed for market sizing
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • BD
  • Cardinal Health
  • Integra LifeSciences
  • Medline Industries Inc.
  • Smiths Group plc
  • The Cooper Companies Inc.
  • MORE
Global Amniocentesis Needle Market 2019-2023

The analyst recognizes the following companies as the key players in the global amniocentesis needle market: BD, Cardinal Health, Integra LifeSciences, Medline Industries, Inc., Smiths Group plc, The Cooper Companies, Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increase in healthcare expenditure in developed countries.”

According to the report, one of the major drivers for this market is the rise in preference of non-invasive and minimally invasive diagnostic procedure.

Further, the report states that one of the major factors hindering the growth of this market is the high cost of procedure.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • BD
  • Cardinal Health
  • Integra LifeSciences
  • Medline Industries Inc.
  • Smiths Group plc
  • The Cooper Companies Inc.
Note: Product cover images may vary from those shown
Adroll
adroll